Calingo
Seed Round in 2024
Calingo is a digital insurance platform that specializes in providing personalized and optimized risk protection directly at the point of sale. The company focuses on offering customized insurance products designed to meet individual customer needs, ensuring transparency and fairness in pricing. By leveraging technology, Calingo aims to deliver tailored insurance solutions that are both suitable and transparent for customers.
Hylomorph
Series B in 2023
Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.
Medyria is a Swiss medtech company developing sensor-based catheter navigation and sensing systems for vascular, valve, and heart procedures. Its products include a sensor-based catheter positioning system for X-ray- and dye-free minimally invasive cardiovascular procedures, Flowcath for measuring blood flow, Trackcath for processing flow data and tracking catheters, and an OEM flow sensor for measuring blood or physiological fluid flow. The company uses proprietary Blood Flow Velocity Sensor technology to enable safer and more effective endovascular procedures by reducing procedural manipulations, duration, complications, and overall costs. Medyria is based in Winterthur, Switzerland.
myFacility
Seed Round in 2022
Oxfia is an energy optimization platform. It can optimize and monitor existing building technology without human interaction and lower energy costs in the building process. They specialize in reducing carbon dioxide emissions and energy costs associated with the operation of building systems, enabling people to minimize their building's energy costs and reduce controllable energy consumption.
Pipra develops an AI-driven clinical decision support software that helps doctors identify high-risk patients prone to post-operative delirium prior to surgery. This tool integrates medical data analysis and predictive modeling, enabling healthcare providers to reduce complications and improve patient outcomes.
REBELS 0.0%
Seed Round in 2022
Rebels 0.0% is a company dedicated to creating truly alcohol-free spirits, aiming to provide consumers with enjoyable alternatives for social drinking. By developing beverages that can be mixed with various drinks while containing no alcohol, Rebels 0.0% promotes a social mission to empower individuals in their choices regarding alcohol consumption. The brand emphasizes the importance of freedom of choice, allowing people to partake in social experiences without the effects of alcohol.
Inergio
Pre Seed Round in 2022
Inergio is a spin-off from the École Polytechnique Fédérale de Lausanne that specializes in the development of advanced fuel cell technology. The company focuses on creating portable energy units that deliver ten times the power while being half the weight of existing solutions. Founded by Mahmoud Hadad, Inergio's innovative fuel cell design utilizes readily available and safe fuels like butane and propane, providing high autonomy for various applications. This modular and miniaturized power system is aimed at addressing the challenge of reliable energy supply, offering a clean, efficient, and lightweight solution. The technology is versatile, suitable for diverse applications, including charging consumer electronics, supplying auxiliary power for drones, and serving as automobile fuel cells. Inergio has developed a working prototype and is in the process of preparing a minimal viable product to initiate pilot projects with potential partners and customers.
Hylomorph
Series B in 2021
Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.
CompPair Technologies
Seed Round in 2021
CompPair Technologies designs and develops smart, bio-inspired healable structural composites to extend the lifespan of composite structures. Serving industries such as aerospace, automotive, wind energy, and sports, their flagship product is Smart Prepreg, which reduces maintenance costs, heals damage, improves sustainability, and enhances product lifetime.
CompPair Technologies
Seed Round in 2021
CompPair Technologies designs and develops smart, bio-inspired healable structural composites to extend the lifespan of composite structures. Serving industries such as aerospace, automotive, wind energy, and sports, their flagship product is Smart Prepreg, which reduces maintenance costs, heals damage, improves sustainability, and enhances product lifetime.
Typewise
Seed Round in 2020
Typewise AG is a Swiss deep tech company established in 2019 and headquartered in Binningen, Switzerland. It specializes in developing innovative text prediction technology and offers a range of products aimed at enhancing communication efficiency. The flagship product, the Typewise Keyboard, is an award-winning app available for iOS and Android that supports over 30 languages and includes features like a custom dictionary and predictive text capabilities, specifically catering to users in multilingual contexts, including support for Hinglish. Additionally, Typewise provides an AI Writing Assistant, a browser-based tool designed to improve the speed and quality of written communication, particularly for customer service and sales teams. The company also offers a Text Prediction API that allows developers to integrate its advanced text prediction capabilities into their own applications, thereby enhancing user experience and productivity. With nearly 2 million installations of its keyboard app, Typewise aims to make everyday communication easier and more efficient.
Hystrix Medical
Seed Round in 2019
Hystrix Medical operates a digital marketplace designed to streamline the procurement process for medical devices and repeat purchase products within hospitals. The platform connects healthcare organizations with suppliers, significantly reducing the typical 4-6 month contracting timeline by providing a comprehensive one-stop shop that establishes a transparent market price landscape. It focuses on medical products that require minimal explanation for transaction, aiming to enhance the efficiency of hospital personnel and suppliers. By facilitating easier and more effective procurement and sales, Hystrix Medical has demonstrated an average total cost savings of 40% for its users, making it a valuable resource in the healthcare supply chain.
Peripal AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in developing and distributing innovative medical devices designed to assist patients undergoing Peritoneal Dialysis at home. Their flagship product, PeriSafe, is a patient-assist device that simplifies the process of connecting dialysis tubings manually, reducing the risk of infection and requiring less dexterity from users. Additionally, they offer PERiPLEX, a diagnostic tool for detecting infections in peritoneal dialysis patients. Peripal's primary focus is on developing products like the Peripal System to support chronic home care patients, aiming to enhance their quality of life while reducing healthcare costs.
Hylomorph
Series A in 2018
Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.
Peripal AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in developing and distributing innovative medical devices designed to assist patients undergoing Peritoneal Dialysis at home. Their flagship product, PeriSafe, is a patient-assist device that simplifies the process of connecting dialysis tubings manually, reducing the risk of infection and requiring less dexterity from users. Additionally, they offer PERiPLEX, a diagnostic tool for detecting infections in peritoneal dialysis patients. Peripal's primary focus is on developing products like the Peripal System to support chronic home care patients, aiming to enhance their quality of life while reducing healthcare costs.
AOT - Advanced Osteotomy Tools
Series C in 2016
Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.
Diviac
Angel Round in 2015
Diviac is a prominent online travel agency specializing in scuba diving, founded in December 2012 in Switzerland. The platform aims to inspire divers to explore more destinations and contribute to ocean conservation. Diviac offers an extensive selection of dive holidays, surpassing competitors in both variety and accessibility. It caters to both group and individual travelers, combining a user-friendly online booking experience with personalized guidance from a global team of scuba travel experts. Additionally, Diviac is committed to sustainability, having launched Diviac Eco Travel, which provides divers with opportunities to engage in vacations that positively impact ocean conservation efforts.
Medyria is a Swiss medtech company developing sensor-based catheter navigation and sensing systems for vascular, valve, and heart procedures. Its products include a sensor-based catheter positioning system for X-ray- and dye-free minimally invasive cardiovascular procedures, Flowcath for measuring blood flow, Trackcath for processing flow data and tracking catheters, and an OEM flow sensor for measuring blood or physiological fluid flow. The company uses proprietary Blood Flow Velocity Sensor technology to enable safer and more effective endovascular procedures by reducing procedural manipulations, duration, complications, and overall costs. Medyria is based in Winterthur, Switzerland.
Bluetector
Series A in 2015
Bluetector AG is a Swiss company specializing in the manufacture of wastewater treatment machinery, particularly focusing on the treatment of manure and biogas digestate. Established in 2012 and based in Root, Switzerland, Bluetector produces innovative wastewater treatment containers and systems. The company's technology provides a cost-effective solution for farms struggling with excess manure by converting it into clean water, thus eliminating the need for costly transport over long distances. By utilizing a containerized filtering system based on biological purification methods, Bluetector offers a sustainable approach to managing liquid waste, allowing environmental companies to clean and reuse wastewater in an environmentally friendly manner. Additionally, the company is involved in constructing and renovating municipal wastewater treatment plants, further contributing to effective wastewater management solutions.
DiviCom
Venture Round in 2014
Divicom is a group of companies specializing in health, with 16 years of history. The experience of their professionals allows Divicom the provision of high quality services with attention constant improvement of cost - effectiveness.
Creoptix AG is a Swiss company specializing in the development of optical instruments and consumables for label-free analysis of molecular interactions, primarily serving the drug discovery industry. Founded in 2009 and headquartered in Wädenswil, Switzerland, with an additional office near Boston, Creoptix focuses on next-generation bioanalytical instruments that leverage proprietary sensor and microfluidics technology. Their flagship product, the Creoptix WAVEsystem, utilizes Grating-Coupled Interferometry (GCI) technology to offer high sensitivity and resolution for real-time analysis of biological interactions, accommodating various samples, including small molecules, peptides, and biologics in complex biofluids like serum and plasma. The company also provides instrument sets for fragment-based screening and binding analysis, versatile sensors for carboxyl-coupling of various molecules, and integrated software for assay setup and data evaluation, catering to both industry and academic research needs.
Leman Micro Devices
Series A in 2013
Leman Micro Devices is a Lausanne, Switzerland-based company that develops health monitoring technology for future smartphones. Founded in 2013, it creates regulated consumer healthcare products for mobile devices, supported by major players in the mobile device industry. Its flagship device, the V-Sensor, is a miniature standalone sensor that measures five vital signs—blood pressure, blood oxygen saturation, respiration rate, pulse rate, and body temperature—cuff-less and calibration-free, with results displayed in under a minute in the e-Checkup app. The company introduced the device at CES 2021 and aims to integrate medical-grade sensing into mobile experiences for remote health monitoring.
Credentis
Series B in 2013
Credentis AG, established in 2010 and headquartered in Windisch, Switzerland, specializes in the research, development, production, and distribution of innovative oral hygiene products. The company focuses on preventing and treating dental diseases, offering solutions such as CURODONT for hypersensitivity treatment and CUROLOX for post-bleaching care. Their product portfolio also includes Curodont Repair, Protect, and D’Senz, targeting caries lesions and related issues. Credentis aims to provide dentists with effective tools and patients with products that regenerate, protect, and desensitize teeth.
Attolight
Series B in 2012
Attolight specializes in electron microscopy and ultrafast spectroscopy, offering innovative solutions that combine cathodoluminescence (CL), light microscopy (LM), and electron microscopy (EM) with hyperspectral imaging. Their products enable high-resolution, time-resolved studies of various materials, particularly semiconductors, phosphors, ceramics, rocks, and glasses, revealing ultra-trace impurities and crystallographic defects otherwise invisible.
Viroblock
Series C in 2012
Viroblock is a Swiss company dedicated to the development of advanced antiviral technology that acts rapidly and has a broad spectrum of efficacy. Their innovative technology is integrated into non-woven fabrics, making it particularly effective for air filtration products. Viroblock's fabric has demonstrated the ability to eliminate over 99% of H5N1 viruses in standardized aerobiology tests. The company employs a unique mechanism of action that enables the inactivation of enveloped viruses, including various strains of influenza, the SARS virus, and the AIDS virus. This broad-spectrum approach allows Viroblock to address multiple virus families without leading to the development of viral resistance, enhancing treatment options for patients affected by viral diseases.
AOT - Advanced Osteotomy Tools
Seed Round in 2012
Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.
Attolight
Seed Round in 2010
Attolight specializes in electron microscopy and ultrafast spectroscopy, offering innovative solutions that combine cathodoluminescence (CL), light microscopy (LM), and electron microscopy (EM) with hyperspectral imaging. Their products enable high-resolution, time-resolved studies of various materials, particularly semiconductors, phosphors, ceramics, rocks, and glasses, revealing ultra-trace impurities and crystallographic defects otherwise invisible.
VirtaMed
Seed Round in 2008
Founded in 2007, VirtaMed develops and produces high-fidelity medical simulators for surgical training. Its portfolio includes simulators for orthopedics, obstetrics & gynecology, laparoscopy, urology, and custom-made solutions. Headquartered in Schlieren, Switzerland, the company aims to improve surgical education programs globally.